Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

13.82
-0.4236-2.97%
Post-market: 13.820.00000.00%16:10 EDT
Volume:16
Turnover:225
Market Cap:207.35K
PE:- -
High:13.82
Open:14.25
Low:13.82
Close:14.25
52wk High:27.19
52wk Low:13.82
Shares:15.00K
Float Shares:15.00K
Volume Ratio:0.12
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 22

Top Midday Stories: Paramount Skydance Settles With US States to Pave Way for Warner Bros. Deal; Anthropic Now Eyeing November IPO

MT Newswires Live
·
Sep 21

Weight-Loss Drug Giant Sheds 13,000 Positions

Deep News
·
Sep 21

Novo Nordisk Details Progress on DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Sep 21

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 7.85%

TIPRANKS
·
Sep 21

Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial

Dow Jones
·
Sep 21

Novo Nordisk A/S Stock (NVO) Moved Down by 7.86% on Sep 21: A Full Analysis

TradingKey
·
Sep 21

Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial

TIPRANKS
·
Sep 21

Sector Update: Healthcare

MT Newswires Live
·
Sep 21

Update: Oil Price Decline Lifts US Equity Futures Pre-Bell

MT Newswires Live
·
Sep 21

Why Novo Stock is Dropping After Drugmaker Unveils Ambitious Growth Plan

Dow Jones
·
Sep 21

【US Pre-Market】US-China Talks Boost Markets, Bitcoin Rises to $85,000, Greenland Concept Stocks Surge, Oil Falls for Fourth Day

TradingKey
·
Sep 21

Novo Nordisk's Weight-Loss, Diabetes Drug Candidate Meets Primary Goals

MT Newswires Live
·
Sep 21

Goldman Sachs Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Sep 21

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Reuters
·
Sep 21

Why Is Novo Stock (NVO) Falling in Pre-Market Today, September 21?

TIPRANKS
·
Sep 21

Novo Nordisk Drops Over 7% Pre-Market as Wegovy Sales Miss Expectations

TradingKey
·
Sep 21

Market Chatter: Novo Nordisk Urged by Shareholders to Develop New Medicines, Pursue Acquisitions

MT Newswires Live
·
Sep 21

Novo Nordisk Aims for $23 Billion in 2035 Pipeline Sales

MT Newswires Live
·
Sep 21